Oxford Nanopore Technologies Stock News

Oxford Nanopore Technologies PLC (LSE:ONT) secured an upgrade to a 'buy' rating from Panmure Liberum on Monday, as analysts cheered a lucrative diagnostics deal despite lingering strategic risks. The shares traded at 165.90p, down 2.41%, even as the broker hiked its target price to 196 pence from 170 pence to reflect the evolving business model.

Oxford Nanopore Technologies PLC (LSE:ONT), the DNA-sequencing technology company, has set a target of more than $700 million in annual revenue by 2030 as it maps out a path to profitability. The company also expects its margin on adjusted earnings, a measure of underlying profitability that excludes items such as interest, tax and depreciation, to exceed 15% by the same date.

Railpen has raised its takeover proposal for IP Group PLC (LSE:IPO), offering shareholders a mix of cash, shares in Oxford Nanopore and a contingent payout linked to the biotech firm Metsera. The pension fund manager, IP Group's largest shareholder with an 18.4% stake, has made two improved proposals to the board since its initial approach on 22 June, following meetings with shareholders and di...

Shares in Oxford Nanopore Technologies PLC (LSE:ONT) fell 16% to 101.2 pence after the company said first-half trading had come in below management expectations. The maker of nanopore-based technology for analysing DNA and RNA, expects revenue of around £116.5 million for the six months to 30 June.